Deciphering the biochemistry and identifying biomarkers to multiple sclerosis.
Proteomics
; 15(19): 3281-2, 2015 Oct.
Article
en En
| MEDLINE
| ID: mdl-26314682
Multiple sclerosis is an idiopathic demyelinating disease of the CNS. Despite being extensively studied during the last decades, many molecular aspects of the disease are still to be elucidated. Moreover, biomarkers for treatment and early diagnosis are major issues to be tackled. In this edition of Kroksveen et al. (Proteomics 2015, 15, 3361-3369) present biomarker candidates for the early detection of multiple sclerosis. Despite the need for validation in larger sets of samples, this dataset contributes to resolve open questions associated to multiple sclerosis.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Cromogranina B
/
Esclerosis Múltiple
Tipo de estudio:
Screening_studies
Límite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Proteomics
Asunto de la revista:
BIOQUIMICA
Año:
2015
Tipo del documento:
Article
País de afiliación:
Brasil
Pais de publicación:
Alemania